BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22613783)

  • 1. Crosstalk between TGF-β signaling and the microRNA machinery.
    Butz H; Rácz K; Hunyady L; Patócs A
    Trends Pharmacol Sci; 2012 Jul; 33(7):382-93. PubMed ID: 22613783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel.
    Tiwari R; Bargmann W; Bose HR
    Virology; 2011 Apr; 413(1):60-71. PubMed ID: 21345476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory machinery for the TGF-β family signaling pathway.
    Itoh S; Itoh F
    Growth Factors; 2011 Oct; 29(5):163-73. PubMed ID: 21913798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta and malignant melanoma: molecular mechanisms.
    Hussein MR
    J Cutan Pathol; 2005 Jul; 32(6):389-95. PubMed ID: 15953371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β.
    Ikushima H; Miyazono K
    Cell Tissue Res; 2012 Jan; 347(1):37-49. PubMed ID: 21618142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β-Regulated MicroRNAs and Their Function in Cancer Biology.
    Yang P; Zhang Y; Markowitz GJ; Guo X; Wang XF
    Methods Mol Biol; 2016; 1344():325-39. PubMed ID: 26520135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin and TGF-β entanglements.
    Meyer C; Liu Y; Dooley S
    J Cell Physiol; 2013 Nov; 228(11):2097-102. PubMed ID: 23559144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
    Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
    J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D; Mauviel A
    Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Delta intracellular domain mediates TGF-beta/Activin signaling through binding to Smads and has an important bi-directional function in the Notch-Delta signaling pathway.
    Hiratochi M; Nagase H; Kuramochi Y; Koh CS; Ohkawara T; Nakayama K
    Nucleic Acids Res; 2007; 35(3):912-22. PubMed ID: 17251195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
    Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
    Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
    Geraldo MV; Yamashita AS; Kimura ET
    Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling.
    Watanabe Y; Itoh S; Goto T; Ohnishi E; Inamitsu M; Itoh F; Satoh K; Wiercinska E; Yang W; Shi L; Tanaka A; Nakano N; Mommaas AM; Shibuya H; Ten Dijke P; Kato M
    Mol Cell; 2010 Jan; 37(1):123-34. PubMed ID: 20129061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy.
    Chou JL; Chen LY; Lai HC; Chan MW
    Expert Opin Ther Targets; 2010 Nov; 14(11):1213-23. PubMed ID: 20925461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
    Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
    Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-1306 Mediates the Feedback Regulation of the TGF-β/SMAD Signaling Pathway in Granulosa Cells.
    Yang L; Du X; Liu L; Cao Q; Pan Z; Li Q
    Cells; 2019 Mar; 8(4):. PubMed ID: 30935128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TGF-beta/Smad in prostate cancer: an update].
    Zha J; Huang YF
    Zhonghua Nan Ke Xue; 2009 Sep; 15(9):840-3. PubMed ID: 19947572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of TGF-beta superfamily signaling through SMAD dephosphorylation--a functional genomic view.
    Lin X; Chen Y; Meng A; Feng X
    J Genet Genomics; 2007 Jan; 34(1):1-9. PubMed ID: 17469772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.